PharmaCyte Biotech, Inc. — All Filings
460 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
4
424B2
424B3
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DFAN14A
EFFECT
NT 10-K
NT 10-Q
NTN 10K
NTN 10Q
PRE 14A
PREC14A
S-3
S-3/A
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001683168-26-001989 | Mar 18, 2026 | Mar 17, 2026 |
| SCHEDULE 13G | — | 0001683168-26-001988 | Mar 18, 2026 | — |
| 10-Q | FORM 10-Q FOR JAN 2026 | 0001683168-26-001917 | Mar 17, 2026 | Jan 31, 2026 |
| ARS | ANNUAL REPORT | 0001683168-26-001600 | Mar 9, 2026 | Apr 30, 2025 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-26-001593 | Mar 9, 2026 | Mar 30, 2026 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001683168-26-001363 | Feb 27, 2026 | Mar 30, 2026 |
| SCHEDULE 13G/A | — | 0001213900-26-016526 | Feb 13, 2026 | — |
| 4 | — | 0001683168-26-000148 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | — | 0001683168-26-000147 | Jan 7, 2026 | Jan 5, 2026 |
| 10-Q | FORM 10-Q FOR OCT 2025 | 0001683168-25-009259 | Dec 18, 2025 | Oct 31, 2025 |
| NT 10-Q | EXTENSION | 0001683168-25-009154 | Dec 15, 2025 | Oct 31, 2025 |
| 4 | — | 0001683168-25-009116 | Dec 12, 2025 | Apr 25, 2025 |
| 4 | — | 0001683168-25-009115 | Dec 12, 2025 | Apr 25, 2025 |
| 4 | — | 0001683168-25-009114 | Dec 12, 2025 | — |
| 4 | — | 0001683168-25-009113 | Dec 12, 2025 | Apr 25, 2025 |
| 4 | — | 0001683168-25-009112 | Dec 12, 2025 | Apr 25, 2025 |
| 8-K | FORM 8-K | 0001683168-25-008947 | Dec 5, 2025 | Dec 1, 2025 |
| 8-K/A | 8-K/A | 0001683168-25-008512 | Nov 18, 2025 | Sep 2, 2025 |
| 4 | — | 0001683168-25-008517 | Nov 18, 2025 | Sep 4, 2025 |
| SCHEDULE 13D/A | — | 0001683168-25-008515 | Nov 18, 2025 | — |
| SCHEDULE 13G/A | — | 0001213900-25-107726 | Nov 7, 2025 | — |
| 8-K | FORM 8-K | 0001683168-25-007871 | Oct 31, 2025 | Oct 30, 2025 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-25-007435 | Oct 6, 2025 | Oct 30, 2025 |
| EFFECT | — | 9999999995-25-003122 | Sep 26, 2025 | — |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001683168-25-007217 | Sep 24, 2025 | Oct 30, 2025 |
| CORRESP | — | 0001683168-25-007214 | Sep 24, 2025 | — |
| UPLOAD | — | 0000000000-25-010346 | Sep 23, 2025 | — |
| S-3 | FORM S-3 | 0001683168-25-007041 | Sep 17, 2025 | — |
| 10-Q | FORM 10-Q FOR JUL 2025 | 0001683168-25-006991 | Sep 15, 2025 | Jul 31, 2025 |
| 8-K | FORM 8-K | 0001683168-25-006727 | Sep 5, 2025 | Sep 2, 2025 |
| D | — | 0001683168-25-006676 | Sep 4, 2025 | — |
| 8-K | CURRENT REPORT | 0001683168-25-006274 | Aug 18, 2025 | Aug 17, 2025 |
| 10-K | FORM 10-K FOR APR 2025 | 0001683168-25-005821 | Aug 11, 2025 | Apr 30, 2025 |
| NT 10-K | EXTENSION | 0001683168-25-005492 | Jul 29, 2025 | Apr 30, 2025 |
| 8-K | FORM 8-K | 0001683168-25-002790 | Apr 24, 2025 | — |
| 10-Q | FORM 10-Q FOR JAN 2025 | 0001683168-25-001669 | Mar 17, 2025 | Jan 31, 2025 |
| ARS | FORM ARS | 0001683168-25-001469 | Mar 10, 2025 | Apr 30, 2024 |
| DEFA14A | FORM DEFA 14A | 0001683168-25-001466 | Mar 10, 2025 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-25-001464 | Mar 10, 2025 | Apr 24, 2025 |
| 8-K | FORM 8-K | 0001683168-25-001236 | Feb 26, 2025 | Feb 21, 2025 |
| SCHEDULE 13G/A | — | 0001493152-25-006360 | Feb 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001213900-25-003823 | Jan 15, 2025 | — |
| 10-Q | FORM 10-Q FOR OCTOBER 2024 | 0001683168-24-008709 | Dec 13, 2024 | Oct 31, 2024 |
| S-8 | REGISTRATION STATEMENT | 0001683168-24-008523 | Dec 4, 2024 | — |
| SC 13G/A | AMENDMENT NO. 4 TO SCHEDULE 13G | 0001213900-24-097260 | Nov 13, 2024 | — |
| 10-Q | FORM 10-Q FOR JULY 2024 | 0001683168-24-006441 | Sep 17, 2024 | Jul 31, 2024 |
| NT 10-Q | EXTENSION | 0001683168-24-006432 | Sep 17, 2024 | Jul 31, 2024 |
| 10-K | FORM 10-K FOR APRIL 2024 | 0001683168-24-005575 | Aug 13, 2024 | Apr 30, 2024 |
| NT 10-K | FORM 12B-25 | 0001683168-24-005109 | Jul 29, 2024 | Apr 30, 2024 |
| 4 | — | 0001683168-24-004918 | Jul 17, 2024 | Apr 30, 2024 |